Through his efforts, this 22-year-old man showed people that an ordinary person can make a contribution through sheer will and determination, says Canadian government
world3 days ago
The US Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of kidney disease, the health regulator's website showed on Wednesday.
The drug, Fabhalta, is already approved to treat adults with paroxysmal nocturnal hemoglobinuria, a rare blood disorder.
With the expanded approval, Novartis' drug entered the IgA nephropathy (IgAN) market and will compete with Swedish drugmaker Calliditas' Tarpeyo and Travere Therapeutics' Filspari.
IgAN — which mostly affects young adults — occurs when clumps of antibodies are deposited in kidneys, causing inflammation that damages their tiny filtering units.
Guggenheim analyst Vamil Divan sees the IgAN market valuing at $10 billion over time as more treatments come to market.
The FDA's latest approval was based on a late-stage trial where Fabhalta showed a 43.8 per cent reduction in proteinuria when compared to placebo.
Proteinuria is excess protein in the urine and can be a sign of the kidney failing to filter properly.
The Swiss drugmaker is also developing two other experimental drugs — zigakibart and atrasentan — for the treatment of IgAN.
The IgAN opportunity is much more tied with the other two drugs than Fabhalta, Divan had told Reuters before the FDA decision.
Otsuka and Vera Therapeutics are also working on treatments for the disease. In April, Vertex Pharmaceuticals had struck a $4.9 billion deal with Alpine Immune Sciences, gaining access to its experimental IgAN drug.
Through his efforts, this 22-year-old man showed people that an ordinary person can make a contribution through sheer will and determination, says Canadian government
world3 days ago
Aftershocks shake the island nation overnight; people queue for fuel and essentials; US, Australia and France send aid, rescue teams
world3 days ago
The 53-year-old from Alabama is currently the only living person with an animal organ transplant
world4 days ago
Sara had been subjected to 'acts of extreme cruelty' but Sharif and Batool had not shown 'a shred of remorse', says judge Cavanagh
world4 days ago
The UNHCR Director said that some of those fleeing could be linked to the former government or else be religious minorities with concerns
world4 days ago
Rafah residents say Israeli tanks pushed deeper towards the western area of Mawasi, known as a humanitarian-designated area
world4 days ago
Kamal Adwan is one of the last operational medical facilities in the north of the war-ravaged territory, with the WHO warning earlier this month that it was operating at a 'minimum' level
world4 days ago
A tsunami warning was issued after the quake, with waves of up to one metre forecast for some areas, but it was soon lifted by the Pacific Tsunami Warning Centre
world4 days ago